Thrombospondins: A Role in Cardiovascular Disease

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2017 Jul 18

PMID 28714932

Citations 31

Authors

Dimitry A Chistiakov

Alexandra A Melnichenko

Veronika A Myasoedova

Andrey V Grechko

Alexander N Orekhov

Affiliations

Soon will be listed here.

Abstract

Thrombospondins (TSPs) represent extracellular matrix (ECM) proteins belonging to the TSP family that comprises five members. All TSPs have a complex multidomain structure that permits the interaction with various partners including other ECM proteins, cytokines, receptors, growth factors, etc. Among TSPs, TSP1, TSP2, and TSP4 are the most studied and functionally tested. TSP1 possesses anti-angiogenic activity and is able to activate transforming growth factor (TGF)-β, a potent profibrotic and anti-inflammatory factor. Both TSP2 and TSP4 are implicated in the control of ECM composition in hypertrophic hearts. TSP1, TSP2, and TSP4 also influence cardiac remodeling by affecting collagen production, activity of matrix metalloproteinases and TGF-β signaling, myofibroblast differentiation, cardiomyocyte apoptosis, and stretch-mediated enhancement of myocardial contraction. The development and evaluation of TSP-deficient animal models provided an option to assess the contribution of TSPs to cardiovascular pathology such as (myocardial infarction) MI, cardiac hypertrophy, heart failure, atherosclerosis, and aortic valve stenosis. Targeting of TSPs has a significant therapeutic value for treatment of cardiovascular disease. The activation of cardiac TSP signaling in stress and pressure overload may be therefore beneficial.

Citing Articles

Role of A Single Nucleotide Polymorphism in Thrombospondine 4 Gene in Premature Myocardial Infarction among Population of Southern Iran.

Farahbakhsh N, Hooshanginezhad Z, Saleh S, Alaei F, Azizi F, Shojaie M ARYA Atheroscler. 2024; 19(2):23-29.

PMID: 38883567 PMC: 11066779. DOI: 10.48305/arya.2023.41105.2846.

Novel Multiplexed Plasma Biomarker Panel Has Diagnostic and Prognostic Potential in Children With Hypertrophic Cardiomyopathy.

Captur G, Doykov I, Chung S, Field E, Barnes A, Zhang E Circ Genom Precis Med. 2024; 17(3):e004448.

PMID: 38847081 PMC: 11188636. DOI: 10.1161/CIRCGEN.123.004448.

Incident heart failure in chronic kidney disease: proteomics informs biology and risk stratification.

Dubin R, Deo R, Ren Y, Wang J, Pico A, Mychaleckyj J Eur Heart J. 2024; 45(30):2752-2767.

PMID: 38757788 PMC: 11313584. DOI: 10.1093/eurheartj/ehae288.

The molecular mechanism of thrombospondin family members in cardiovascular diseases.

Pan H, Lu X, Ye D, Feng Y, Wan J, Ye J Front Cardiovasc Med. 2024; 11:1337586.

PMID: 38516004 PMC: 10954798. DOI: 10.3389/fcvm.2024.1337586.

Machine learning-based biomarker profile derived from 4210 serially measured proteins predicts clinical outcome of patients with heart failure.

de Bakker M, Petersen T, Rueten-Budde A, Akkerhuis K, Umans V, Brugts J Eur Heart J Digit Health. 2023; 4(6):444-454.

PMID: 38045440 PMC: 10689916. DOI: 10.1093/ehjdh/ztad056.

References

Murphy-Ullrich J, Sage E . Revisiting the matricellular concept. Matrix Biol. 2014; 37:1-14. PMC: 4379989. DOI: 10.1016/j.matbio.2014.07.005. View

Sage E, Mercier O, Van den Eyden F, de Perrot M, Barlier-Mur A, Dartevelle P . Endothelial cell apoptosis in chronically obstructed and reperfused pulmonary artery. Respir Res. 2008; 9:19. PMC: 2263036. DOI: 10.1186/1465-9921-9-19. View

Chatila K, Ren G, Xia Y, Huebener P, Bujak M, Frangogiannis N . The role of the thrombospondins in healing myocardial infarcts. Cardiovasc Hematol Agents Med Chem. 2007; 5(1):21-7. DOI: 10.2174/187152507779315813. View

Farb A, Burke A, Tang A, Liang T, Mannan P, Smialek J . Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996; 93(7):1354-63. DOI: 10.1161/01.cir.93.7.1354. View

Lu X, Murphy T, Nanes M, Hart C . PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B. Am J Physiol Lung Cell Mol Physiol. 2010; 299(4):L559-66. PMC: 2957423. DOI: 10.1152/ajplung.00090.2010. View

Bazzazi H, Isenberg J, Popel A . Inhibition of VEGFR2 Activation and Its Downstream Signaling to ERK1/2 and Calcium by Thrombospondin-1 (TSP1): Investigation. Front Physiol. 2017; 8:48. PMC: 5292565. DOI: 10.3389/fphys.2017.00048. View

Kaur S, Martin-Manso G, Pendrak M, Garfield S, Isenberg J, Roberts D . Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47. J Biol Chem. 2010; 285(50):38923-32. PMC: 2998110. DOI: 10.1074/jbc.M110.172304. View

Streit M, Riccardi L, Velasco P, Brown L, Hawighorst T, Bornstein P . Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc Natl Acad Sci U S A. 1999; 96(26):14888-93. PMC: 24743. DOI: 10.1073/pnas.96.26.14888. View

Silverstein R, Febbraio M . CD36-TSP-HRGP interactions in the regulation of angiogenesis. Curr Pharm Des. 2008; 13(35):3559-67. DOI: 10.2174/138161207782794185. View

10.

Patra D, Sandell L . Antiangiogenic and anticancer molecules in cartilage. Expert Rev Mol Med. 2012; 14:e10. DOI: 10.1017/erm.2012.3. View

11.

Lamy L, Foussat A, Brown E, Bornstein P, Ticchioni M, Bernard A . Interactions between CD47 and thrombospondin reduce inflammation. J Immunol. 2007; 178(9):5930-9. DOI: 10.4049/jimmunol.178.9.5930. View

12.

Lin T, Kim G, Chen J, Cheung W, He Y, Hsu C . Differential regulation of thrombospondin-1 and thrombospondin-2 after focal cerebral ischemia/reperfusion. Stroke. 2003; 34(1):177-86. DOI: 10.1161/01.str.0000047100.84604.ba. View

13.

Gao Z, Kim G, Mackinnon A, Flagg A, Bassett B, Earley J . Ets1 is required for proper migration and differentiation of the cardiac neural crest. Development. 2010; 137(9):1543-51. PMC: 2853851. DOI: 10.1242/dev.047696. View

14.

Papageorgiou A, Swinnen M, Vanhoutte D, VandenDriessche T, Chuah M, Lindner D . Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cells. Cardiovasc Res. 2012; 94(1):115-24. DOI: 10.1093/cvr/cvs077. View

15.

Reed M, OBrien E, Truong T, LaBell T, Bornstein P, Sage E . Expression of thrombospondins by endothelial cells. Injury is correlated with TSP-1. Am J Pathol. 1995; 147(4):1068-80. PMC: 1870996. View

16.

Tsai A, Berka V, Sharina I, Martin E . Dynamic ligand exchange in soluble guanylyl cyclase (sGC): implications for sGC regulation and desensitization. J Biol Chem. 2011; 286(50):43182-92. PMC: 3234846. DOI: 10.1074/jbc.M111.290304. View

17.

Ochoa C, Yu L, Al-Ansari E, Hales C, Quinn D . Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension. J Cardiothorac Surg. 2010; 5:32. PMC: 2877040. DOI: 10.1186/1749-8090-5-32. View

18.

Chen C, Lau L . Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol. 2008; 41(4):771-83. PMC: 2668982. DOI: 10.1016/j.biocel.2008.07.025. View

19.

Belmadani S, Bernal J, Wei C, Pallero M, DellItalia L, Murphy-Ullrich J . A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II. Am J Pathol. 2007; 171(3):777-89. PMC: 1959499. DOI: 10.2353/ajpath.2007.070056. View

20.

AshokKumar M, Anbarasan C, Saibabu R, Kuram S, Raman S, Cherian K . An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians. Thromb Res. 2011; 128(4):e49-53. DOI: 10.1016/j.thromres.2011.05.026. View